EVOGENE LTD's ticker is EVGN and the CUSIP is M4119S104. A total of 35 filers reported holding EVOGENE LTD in Q3 2023. The put-call ratio across all filers is 2.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7 | -41.7% | 11,355 | 0.0% | 0.00% | – |
| Q2 2023 | $12 | +71.4% | 11,355 | 0.0% | 0.00% | – |
| Q1 2023 | $7 | 0.0% | 11,355 | 0.0% | 0.00% | – |
| Q4 2022 | $7 | -99.9% | 11,355 | -32.2% | 0.00% | – |
| Q3 2022 | $13,000 | +18.2% | 16,738 | +10.0% | 0.00% | – |
| Q2 2022 | $11,000 | -42.1% | 15,223 | +3.4% | 0.00% | – |
| Q1 2022 | $19,000 | -20.8% | 14,723 | -3.3% | 0.00% | – |
| Q4 2021 | $24,000 | -35.1% | 15,223 | +8.0% | 0.00% | – |
| Q3 2021 | $37,000 | -26.0% | 14,098 | -4.2% | 0.00% | – |
| Q2 2021 | $50,000 | -30.6% | 14,723 | +2.1% | 0.00% | – |
| Q1 2021 | $72,000 | -25.0% | 14,423 | -30.1% | 0.00% | – |
| Q4 2020 | $96,000 | – | 20,633 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eidelman Virant Capital | 117,000 | $101,000 | 0.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,322 | $156,000 | 0.05% |
| Senvest Management, LLC | 230,606 | $178,000 | 0.01% |
| Susquehanna International Group Ltd. | 28,718 | $21,000 | 0.01% |
| Vident Investment Advisory, LLC | 87,714 | $68,000 | 0.00% |
| MGO ONE SEVEN LLC | 15,340 | $12,000 | 0.00% |
| Csenge Advisory Group | 31,962 | $24,000 | 0.00% |
| SNS Financial Group, LLC | 10,000 | $8,000 | 0.00% |
| Sigma Planning Corp | 31,810 | $24,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 10,249 | $8,000 | 0.00% |